![Greg Misson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Greg Misson is currently the Managing Director at Eqalis Pharmaceuticals Ltd.
He previously worked as the Executive Director & Chief Innovation Officer at Cannasouth Ltd.
Cargos activos de Greg Misson
Empresas | Cargo | Inicio |
---|---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Director Ejecutivo | - |
Antiguos cargos conocidos de Greg Misson.
Empresas | Cargo | Fin |
---|---|---|
CANNASOUTH LIMITED | Director Técnico/Científico/I+D | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CANNASOUTH LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
Eqalis Pharmaceuticals Ltd
![]() Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Bolsa de valores
- Insiders
- Greg Misson